Alphabet
Wall Street extends rout, CrowdStrike slumps on global tech outage
Wall Street’s main indexes fell on Friday, while investors assessed the impact of a global cyber outage that knocked down CrowdStrike’s shares to an over two-month low.
$32
Donanemab, Eli Lilly’s Early Alzheimer’s Disease Treatment Approved By FDA
Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer’s disease.
Business
Eli Lilly’s obesity drug now available in U.S. pharmacies
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
Addiction control
Weight loss drugs transforming healthcare, may help with addiction
A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas.
alzheimer
New Alzheimer’s Drug Slows Early Stages Of Disease
A new study revealed that Lilly Biotechnology Center’s Alzheimer’s drug slowed the disease by as much as 22% to 35%, compared to a separate placebo study.
California
California sues insulin makers
California is in the process of filing lawsuits against a group of pharmacy benefit managers and insulin manufacturers for using “unlawful, unfair, and deceptive” means to drive up costs.